微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.82% | -31.67% | -43.06% | 89/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 1.44% | -65.3% | 596.55% | 94/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -0.29% | -105.14% | -114.01% | 115/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.07% | -40% | 72.5% | 81/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.2% | -66.94% | -71.08% | 85/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.15% | 56.02% | -26.42% | 70/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.64% | 28.77% | 63.48% | 60/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.45% | 31.68% | -4.96% | 63/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.63% | 188.1% | 36.47% | 22/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.66% | -39.55% | -39.27% | 90/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.38% | -47.86% | 67.18% | 69/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.62% | -9.97% | 107.94% | 73/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.26% | -33.33% | -71.36% | 81/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 4.4% | 64.18% | -47.62% | 82/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.4% | 37.48% | 188.66% | 50/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.91% | 67.24% | 53.97% | 81/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.89% | 48.82% | -29.48% | 70/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 2.68% | -69.55% | -56.14% | 98/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 6.11% | -42.95% | 251.15% | 65/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.74% | -74.78% | 37.01% | 93/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.27% | -70.87% | -85.57% | 62/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.8% | -29.88% | -17.83% | 64/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 10.71% | -11.71% | 55.22% | 30/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.9% | -8.49% | 58.26% | 29/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.36% | 4.31% | -65.26% | 15/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 12.55% | 49.58% | 3.46% | 38/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 12.13% | 25.96% | 60.88% | 14/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.54% | 57.08% | 80.38% | 18/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 4.18% | 30.22% | -50.18% | 14/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.39% | -24.55% | -12.88% | 60/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 9.63% | 0.52% | 100.63% | 32/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.8% | -26.15% | 49.53% | 46/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.21% | -21.52% | -71.13% | 22/158 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 11.12% | -28.67% | 16.08% | 48/158 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 9.58% | -37.63% | 47.38% | 25/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 6.5% | -26.8% | 58.92% | 29/158 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 4.09% | -25.91% | -73.77% | 18/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 15.59% | -30.31% | 1.5% | 33/158 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 15.36% | -18.69% | 72.97% | 11/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 8.88% | -27.45% | 60.87% | 16/158 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 5.52% | -13.34% | -75.32% | 9/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |